How Memorial Hermann is bringing precision healthcare to Texans with population genomics

Wednesday, September 7th, 2022 | 11:00 AM - 12:00 PM CT

A new standard of care is emerging. Broad genetic screening and genomics are helping to deliver precision healthcare at scale. Houston-based Memorial Hermann Health System — a nonprofit, award-winning organization — is committed to bringing more personalized and proactive care using population genomics.

In this session, Feby Abraham, Memorial Hermann Health System's chief strategy officer, and James Lu, the CEO and cofounder of Helix, will discuss how genomics is changing clinical care and why Memorial Hermann chose to get involved.

Key takeaways:
  • Understand the benefits of population genomics for patients and health systems
  • The current models being used for population genomics initiatives
  • How Memorial Hermann is enabling precision healthcare with population-scale genomics


Feby-Abraham-Headshot - Maddi Billings

Feby Abraham

PhD Chief Strategy Officer Memorial Hermann Health System

James Lu - Maddi Billings

James Lu

MD, PhD CEO & Co-Founder Helix